Insider trade

Promis Neurosciences (PMN): Director bought ~$91K

Eugene Williams, Director at Promis Neurosciences, bought ~$91K of Promis Neurosciences shares.

~$91K
Approx. value · 27K sh @ $3.43: 40K
Holds after · shares reported

Traded: Nov 4, 2026
Filed: Nov 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 30, 2026Insider · 13 days before resultsDirector purchased ~$5.3K of PMN shares in the open market
Nov 2, 2026Insider · 10 days before resultsDirector purchased ~$39K of PMN shares in the open market
Nov 4, 2026 · this disclosureInsider · 8 days before resultsDirector purchased ~$91K of PMN shares in the open market

What came next

Nov 12, 2026Company filing · Form 8-K · ResultsReported its results
Nov 12, 20265% stakeAdage Capital Management, L.P. reported a passive stake (13G) of 7.7%

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Promis Neurosciences

For Promis Neurosciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PMN page.

Other recent filings by Eugene Williams, Director

The full history of Eugene Williams, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Promis Neurosciences

Everything OQRO holds on this company is on its PMN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data